GSK3B and pulmonary fibrosis: The activity of GSK3β is closely associated with pulmonary fibrosis and lung aging, where the phosphorylation of GSK3β at Ser21 and Ser9 leads to decreased activity, thereby inhibiting pulmonary fibrosis and lung aging [69,70].